FIELD: organic synthesis. SUBSTANCE: invention provides novel derivatives of N-(3-benzofuranyl)urea having general formula I: (I), where A and D, identical or different, denote hydrogen, linear or branched C1-C6-acyl, linear or branched alkoxycarbonyl with 1-6 carbon atoms in its alkoxy moiety, halogen, OR4 group, wherein R4 is hydrogen, linear or branched C1-C8-alkyl, alkoxycarbonyl with 1-6 carbon atoms in its alkoxy moiety, benzyl, group, wherein R5 is , linear or branched C1-C4-alkyl, or group , wherein R6 is phenyl; L is oxygen or sulfur atom; R1 and R2, identical or different, denote hydrogen, cycloalkyl with up to 6 carbon atoms, linear or branched C1-C8-alkyl, C1-C8-alkoxycarbonyl, C2-C8-alkenyl, or benzoyl, or yet R1 and R2 in common with nitrogen atom form 5-7-membered saturated heterocycle; R3 is phenyl optionally substituted by 1 to 3 identical or different substituents from group including halogen, nitro, C1-C8-alkyl or C1-C8-alkoxy; in the form of isomer mixtures or individual isomers or their salts. Compounds I are biologically active. In particular, they inhibit lipoxygenase and can be useful in treatment of acute or chronic inflammatory conditions. EFFECT: extended choice of antiinflammatory agents. 14 cl, 11 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZOFURANYLALKANE CARBOXYLIC ACID OR A MIXTURE OF THEIR ISOMERS, OR SEPARATE ISOMERS, OR THEIR SALTS | 1994 |
|
RU2125564C1 |
DERIVATIVES OF CYCLOALKANOINDOLE AND AZAINDOLE, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, DERIVATIVES OF CARBOXYLIC ACID AS PARENT COMPOUNDS AND PHARMACEUTICAL COMPOSITION INHIBITING RELEASE OF LIPOPROTEINS ASSOCIATED WITH APOLIPOPROTEIN B-100 | 1995 |
|
RU2157803C2 |
4H-PYRAN DERIVATIVES, MIXTURE OF ISOMERS THEREOF, INDIVIDUAL ISOMERS AND SALTS THEREOF | 1996 |
|
RU2164915C2 |
CYCLIC THIO-SUBSTITUTED DERIVATIVES OF ACYLAMINO ACID AMIDE AND METHOD OF THEIR SYNTHESIS | 1998 |
|
RU2193556C2 |
DIHYDROPYRIDINE DERIVATIVES, MIXTURE OF THEIR ISOMERS, INDIVIDUAL ISOMERS OR THEIR PHYSIOLOGICALLY TOLERANTABLE SALTS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2081872C1 |
DERIVATIVES OF HETEROCYCLE-SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND THEIR SALTS | 1994 |
|
RU2125990C1 |
2,8-DISUBSTITUTED QUINAZOLINONE DERIVATIVES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS BASED ON THE LATTER AFFECTING BLOOD LEVELS OF GUANOSINE AND ADENOSINE MONOPHOSPHATES | 1996 |
|
RU2158733C2 |
DERIVATIVES OF QUINOLINE CARBOXYLIC ACID, MIXTURE OF ISOMERS OR INDIVIDUAL ISOMERS, THEIR PHARMACEUTICALLY ACCEPTABLE HYDRATES AND SALTS, METHOD FOR THEIR PRODUCTION | 1992 |
|
RU2077533C1 |
ENDOPARASITICIDIC AGENT | 1995 |
|
RU2124364C1 |
DERIVATIVES OF CYCLOHEXADIENE, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND THEIR SALTS AND PHARMACEUTICAL COMPOSITION WITH SELECTIVE MODULATING EFFECT ON CALCIUM-DEPENDENT POTASSIUM CHANNELS OF HIGH CONDUCTIVITY | 1995 |
|
RU2155748C2 |
Authors
Dates
2001-02-10—Published
1996-03-05—Filed